CompanyOverview|NASDAQ:REGN] Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has gone relatively unnoticed from major ...
The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza ...
Revolving door is a VERY polite term for Patrizia Cavazzoni's moves. Then again, she has a 25-year history of picking Big Pharma over vulnerable patients. She'll fit right in with Scott Gottlieb.
India remains a preferred outsourcing destination, with a 30–35 per cent cost advantage over Western competitors. Emerging ...
A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...
GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical ...
Zipalertinib pivotal Phase 2b study met primary endpoint; full results mid-year 2025 and NDA submission planned H2 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback